18 November 2024

Law and life sciences

An article by Federica Fogliano and Dario Quaranta | Cattolica News

The topicality of the topics covered, the exceptional faculty, the close collaboration with companies, the possibility of being able to count on a solid network with the world of work. These are the strengths of the new Executive & Continuing Education Course entitled "Law and Life Sciences. The legal profiles of the pharma, biotech, medical devices & cosmetics worlds", promoted by the Graduate School "Federico Stella" on Criminal Justice (ASGP) and presented on Wednesday 6 November during a meeting hosted by the Sala Blacks da Oleggio of the Catholic University of the Sacred Heart.
 

Illustrating its aims, after the introductory greetings of the Dean of the Faculty of Law Stefano Solimano, was the director Matteo Caputo, full professor of Criminal Law. Specifically, the course of the Graduate School aims to provide participants with an in-depth knowledge of the main legal profiles governing the areas of drugs, medical devices, biotechnology, cosmetics and supplements. For this reason, it consists of modules both ad hoc for each sector of Life Sciences and dedicated to the analysis of the various legal aspects that affect this area, including those concerning the issues of procurement, trademarks and patents, intellectual property and the civil and criminal liability of operators.
 

After all, as Gabrio Forti, emeritus of Criminal Law and member of the Accademia dei Lincei as well as founder of the Graduate School "Federico Stella" on Criminal Justice, recalled , when we talk about Life Sciences we refer to a vast field of study that embraces various disciplines, such as biology, biochemistry, pharmacology and genetics. According to Professor Forti, the issue is of particular relevance in today's context, as we are witnessing an era of extraordinary technological evolution that is profoundly redefining every aspect of our lives, including that of health. The advent of artificial intelligence, telemedicine and genomics promises to revolutionise the prevention, diagnosis and treatment of diseases, offering previously unimaginable prospects. Recent advances in research and innovation have proven essential in addressing global challenges, such as the COVID-19 pandemic.
 

The conference discussants, professionals who have made Life Sciences their vocation, dealt with the transformations taking place in the health care sector. The first to take the floor were Paola Testori Coggi and Michele Perrino, respectively Ambassador for Future of Health of the Federated Innovation @MIND and CEO of Demetra Holding and Tecres s.p.a. The speakers illustrated the main innovations in the European and American panorama in health care, highlighting phenomena such as de-hospitalization, the difficult balance between lifestyles, production costs of drugs and biomedical devices and access to the health system. Subsequently, the lawyer Daria Ghidoni, Of Counsel of Bonelli Erede, and Antonio Oliva, Professor of Forensic Medicine at the Catholic University, spoke, who described the legal and medico-legal repercussions of the innovations that characterize the main trends in the pharmaceutical and biomedical sector.
 

A multi-voiced discussion from which it emerged that concrete and significant results can only be achieved through a joint approach between legal professionals and Life Sciences experts . The complexity of the issues requires not only a collaboration characterized by interdisciplinarity, but also the training of new professionals in the legal field, capable of facing and "dominating" the challenges proposed by this sector, also leveraging the so-called soft skills.
 

In this perspective, the Executive & Continuing Education Course in "Law and Life Sciences" offers the necessary skills to respond effectively to current challenges, enabling professionals to combine a solid legal education with a deep understanding of the main economic, organizational and cultural issues that agitate the Life Sciences.